These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 16838038

  • 21. Parathyroid hormone assay: problems and opportunities.
    Martin KJ, González EA.
    Pediatr Nephrol; 2007 Oct; 22(10):1651-4. PubMed ID: 17574479
    [Abstract] [Full Text] [Related]

  • 22. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G, Mazzaferro S, Ballanti P, Bonucci E.
    J Endocrinol Invest; 1992 Oct; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract] [Full Text] [Related]

  • 23. Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India.
    Sankarasubbaiyan S, Abraham G, Soundararajan P, Chandrasekaran V, Padma G.
    Hemodial Int; 2005 Jan; 9(1):63-7. PubMed ID: 16191055
    [Abstract] [Full Text] [Related]

  • 24. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
    Ziółkowska H, Roszkowska-Blaim M.
    Przegl Lek; 2006 Jan; 63 Suppl 3():149-52. PubMed ID: 16898516
    [Abstract] [Full Text] [Related]

  • 25. Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients.
    Cavalier E, Delanaye P, Krzesinski JM, Chapelle JP.
    Clin Chem Lab Med; 2005 Jan; 43(8):890-1. PubMed ID: 16201903
    [No Abstract] [Full Text] [Related]

  • 26. Parathyroid hormone measurements in hemodialysis patients as assessments of renal osteodystrophy.
    Aubry WM, Sparks JC, Braunstein GD.
    Mt Sinai J Med; 1984 Apr; 51(2):132-7. PubMed ID: 6610110
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients.
    Sheth RD, Goldstein SL.
    Pediatr Nephrol; 2005 Jul; 20(7):977-81. PubMed ID: 15856315
    [Abstract] [Full Text] [Related]

  • 28. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
    Kakuta T, Ishida M, Fukagawa M.
    Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
    [Abstract] [Full Text] [Related]

  • 29. Pth 1-84, Pth fragments and bone turnover.
    Malluche HH, Monier-Faugere MC.
    Am J Kidney Dis; 2003 May; 41(5):1127. PubMed ID: 12722056
    [No Abstract] [Full Text] [Related]

  • 30. [Whole PTH and 1-84/84 PTH ratio for the non invasive determination of low bone turnover in renal osteodysthrophy].
    Negri AL, Alvarez Quiroga M, Bravo M, Fradinger E, Jacobo de Marino A, Bogado CE, Zanchetta JR.
    Nefrologia; 2003 May; 23(4):327-32. PubMed ID: 14558332
    [Abstract] [Full Text] [Related]

  • 31. Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy.
    Godber IM, Parker CR, Lawson N, Hitch T, Porter CJ, Roe SD, Cassidy MJ, Hosking DJ.
    Ann Clin Biochem; 2002 May; 39(Pt 3):314-7. PubMed ID: 12038608
    [Abstract] [Full Text] [Related]

  • 32. [Mid C regional parathyroid hormone in the clinical workup: diagnostic value in extrarenal (primary) and renal (secondary) hyperparathyroidism].
    Jüppner H, Atkinson M, Ringe B, Krohn HP, Hesch RD.
    Klin Wochenschr; 1986 Mar 17; 64(6):281-6. PubMed ID: 3520130
    [Abstract] [Full Text] [Related]

  • 33. Target levels for serum phosphorus and parathyroid hormone.
    Qunibi W, Kalantar-Zadeh K.
    Semin Dial; 2011 Mar 17; 24(1):29-33. PubMed ID: 21324001
    [No Abstract] [Full Text] [Related]

  • 34. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
    Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz AR.
    Clin Nephrol; 2004 May 17; 61(5):337-43. PubMed ID: 15182128
    [Abstract] [Full Text] [Related]

  • 35. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed.
    Ferreira MA.
    Nephrol Dial Transplant; 2000 May 17; 15 Suppl 5():8-14. PubMed ID: 11073268
    [No Abstract] [Full Text] [Related]

  • 36. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment.
    White CA, Sarabia S, Collier CP, McCudden C, Holden RM.
    Clin Biochem; 2021 Aug 17; 94():62-66. PubMed ID: 33895125
    [Abstract] [Full Text] [Related]

  • 37. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions.
    Cantor T, Yang Z, Caraiani N, Ilamathi E.
    Clin Chem; 2006 Sep 17; 52(9):1771-6. PubMed ID: 16858070
    [Abstract] [Full Text] [Related]

  • 38. Parathyroid hormone: new assays, new receptors.
    Martin KJ, Akhtar I, González EA.
    Semin Nephrol; 2004 Jan 17; 24(1):3-9. PubMed ID: 14730504
    [Abstract] [Full Text] [Related]

  • 39. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
    Weglarska J, Ziółkowska H, Pańczyk-Tomaszewska M, Sieniawska M.
    Pediatr Pol; 1995 Dec 17; 70(12):1011-5. PubMed ID: 8649939
    [Abstract] [Full Text] [Related]

  • 40. [Parathormone and chronic kidney disease].
    Bacchetta J, Jolivot A, Souberbielle JC, Charrié A, Guebre F, Chauvet C, Fouque D.
    Nephrol Ther; 2007 Jul 17; 3(4):133-8. PubMed ID: 17658439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.